EUDA Health Holdings Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of April 2026 for EUDA Health Holdings Limited, a foreign private issuer headquartered in Singapore. The report is filed pursuant to Rule 13a-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a notification of an "Other Event" rather than a financial results announcement.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this document. The filing solely references the issuance of a press release dated April 28, 2026, which is attached as Exhibit 99.1.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the procedural notification of the press release.
Key Facts for Investors
- The company issued a press release on April 28, 2026, which is the primary subject of this filing.
- Financial performance data is not included in this specific Form 6-K text.
- Investors must review Exhibit 99.1 (the press release) for details regarding the event announced.
- The report was signed by Alfred Lim, Chief Executive Officer.